432 related articles for article (PubMed ID: 15372629)
1. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Mar; 279(10):8567-76. PubMed ID: 14676209
[TBL] [Abstract][Full Text] [Related]
3. Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways.
Inagaki K; Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Kondo T; Kurita N; Kitanaka T; Yamada Y; Sakamoto Y; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2005 Sep; 280(36):31428-37. PubMed ID: 16002410
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
5. c-Src and hydrogen peroxide mediate transforming growth factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells.
Sato M; Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Ohyama Y; Suga T; Maeno T; Aoki Y; Tamura J; Sakamoto H; Nagai R; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):341-7. PubMed ID: 15591224
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
9. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade.
Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Mar; 278(10):7790-9. PubMed ID: 12496270
[TBL] [Abstract][Full Text] [Related]
10. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
12. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
[TBL] [Abstract][Full Text] [Related]
13. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.
Xu G; Chakraborty C; Lala PK
Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587
[TBL] [Abstract][Full Text] [Related]
14. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.
Samarakoon R; Chitnis SS; Higgins SP; Higgins CE; Krepinsky JC; Higgins PJ
PLoS One; 2011; 6(7):e22896. PubMed ID: 21829547
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
18. Effects of TGF-β1 on plasminogen activation in human dental pulp cells: Role of ALK5/Smad2, TAK1 and MEK/ERK signalling.
Chang MC; Chang HH; Lin PS; Huang YA; Chan CP; Tsai YL; Lee SY; Jeng PY; Kuo HY; Yeung SY; Jeng JH
J Tissue Eng Regen Med; 2018 Apr; 12(4):854-863. PubMed ID: 27723266
[TBL] [Abstract][Full Text] [Related]
19. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
